Rhodiola Supplement Manufacturer

An RFQ that says “rhodiola, 3% standardized, 500 mg” is not yet a material. Most failed samples on this botanical fail on species or on which analyte the percentage was. Price is the last field.

01 Species — R. rosea vs R. crenulata

A quotation line that says rhodiola and a COA that says Rhodiola crenulata are not the same drum. R. rosea is the species that supports a meaningful rosavins conversation. R. crenulata (大花红景天) is widely traded on salidroside; it typically carries little or no rosavin / rosarin / rosin. HPTLC (or the named identity method) belongs on the incoming file. Do not blend the two species into one “rhodiola mg.”

02 Plant Part — Root / rhizome

The default medicinal part on this page is root and rhizome. Aerial parts, leaf, or an unnamed “herb” line are a different PO. Lock plant part on the specification before you compare price.

03 Marker Pair — Total rosavins + salidroside

Rosavins are the phenylpropanoid glycosides rosavin, rosarin, and rosin—characteristic of R. rosea. Salidroside is a phenylethanoid glycoside found across Rhodiola species. They are different HPLC peaks. Rosavin (single peak) is not total rosavins.

On this page, dual-marker specification means total rosavins plus salidroside, with the analytes, methods, and assay basis defined on the approved specification. 3% on a dual-marker sheet means total rosavins (rosarin + rosavin + rosin), not a single rosavin peak. 1% means salidroside. Both are HPLC.

The dual-marker grades we quote are listed in Available Specifications below. Two drums with the same printed pair are still different materials until method, milligram basis, and incoming vs finished-unit assay match.

A COA that reports only salidroside—even at 3%—cannot be sampled as a dual-marker rosea capsule. If the panel will print both numbers, both analytes and both methods go on the PO.

04 Assay Basis — Incoming drum vs finished unit

Incoming COA ≠ finished-unit assay. Write whether the dual-marker numbers apply to the incoming extract or the finished unit. A finished-capsule guarantee needs a finished assay. Extract milligrams and root-powder milligrams are different bases.

05 Origin / Trademark

Altai, Siberia, “arctic,” Himalaya, or a Tibetan plateau story does not prove rosavins. Plateau / Tibet wording on open-market sheets often tracks R. crenulata. Name origin on the PO when the label will state it.

Trademarked extract names (including SHR-5®, Rhodiolife®, and Arctic Root®) are used only when the BOM specifically requires the branded ingredient and the applicable authorization or licensing documentation is available. A hydroethanolic dual-marker extract is not those brands.

Sourcing paperwork (bulk). Rhodiola spp. have been listed in CITES Appendix II since 23 February 2023, with annotation #2: all parts and derivatives except seeds, pollen, and finished products packaged and ready for retail trade. Bulk root, powder, and extract remain in scope. Destination-country implementation should be confirmed on the live shipment file.

China’s 2021 National Key Protected Wild Plants List includes R. rosea (and several other Rhodiola species) as Class II. Wild-origin lots may need additional Chinese documentation. A wild drum without a legal-origin file is not a cheaper rosea grade.

Rhodiola extract powder

Extract powder is often pink-brown to rose-brown. Color is not a rosavin assay.

Do not rank two “3%” prices until species, both analytes, method, and milligram basis match.

These are quoteable identity and dual-marker grades for finished-unit OEM and for bulk qualification into a KS filling line. They are not licensed branded extracts and not a website warehouse list. Each lot still locks R. rosea root / rhizome, both HPLC analytes where markers are printed, milligram basis, and whether the numbers apply to the incoming drum or the finished unit.

How to read the pair. Total rosavins = rosarin + rosavin + rosin. Salidroside is a separate HPLC peak. A 3%/1% drum and a 5%/1% drum are different materials. Carriers used to hit a target % belong on the specification, the COA, and the finished ingredient list.

Root powder — what we lock. Botanical Rhodiola rosea L.; part = root and rhizome; form = powder; identity by HPTLC or the named botanical method. Particle size, moisture, ash, microbiology, metals, and pesticides are written on the approved specification and destination file—not copied from this page as a universal COA. Native root powder does not print a dual-marker % unless that lot is actually standardized. Typical bulk pack talk is 25 kg drum or a customer-qualified pack.

Trademarked extracts are a different PO from every row above.

Request a specification review — send the grade you want, or two COAs if you are comparing price.

Field-by-field reading follows the same method as How to Read a COA.

Compare two COAs

R. crenulata is not a cheaper R. rosea. Isolated salidroside is not offered as a dietary-supplement SKU.

Request a specification review — missing species, analyte, method, and milligram-basis fields are listed before anyone quotes.

A usable PO names species, root / rhizome, extract type, the dual-marker specification, HPLC, milligram basis, and whether those numbers apply to the incoming extract or the finished unit. Moisture, metals, micro, and residual solvents (if the solvent is not water) sit on the same sheet.

How standardized botanical POs are written: standard extracts.

Write the analyte next to every percentage. A 5%/2% request is a different quote on the same R. rosea pair—not a second species and not a licensed branded extract. Carriers used to hit a target % (maltodextrin or another diluent) belong on the specification, the COA, and the finished ingredient list.

Incoming physical talk on many dry-extract sheets (illustration, not a catalog promise): pink-brown to rose-brown powder; often ≥95% through 80 mesh; loss on drying commonly discussed at ≤5%; ash ≤8%. None of those rows replace HPLC.

EU traditional-herbal medicine specifications may define rhodiola extracts by DER and extraction solvent. Those medicinal-product parameters should not be copied directly into a U.S. dietary-supplement specification.

Label milligrams and marker math for the panel—not a consumer serving recommendation.

Common extract panels: 200, 300, or 500 mg extract. Duals often drop rhodiola to 100–250 mg so the second identity fits one unit.

Illustration using standard extract 3% / 1% (total rosavins ≥3.0% / salidroside ≥1.0% on that extract, HPLC):

That math holds only when both percentages are defined on the incoming extract as filled and the HPLC methods match. A finished-capsule guarantee needs a finished assay. Root-powder milligrams are a different basis: 500 mg root powder is not 500 mg of dual-marker extract. Do not back-calculate a dual-marker capsule from a root-powder serving.

Many Western commercial labels position rhodiola for daytime use; final timing language should follow the destination-market review. Evening use and “may affect sleep” belong on the warning set. If ashwagandha or magnesium shares the same unit, lock one timing line or split the SKU.

A kg quotation is not a bottle MOQ. Bulk is for brands that already fill, or for incoming qualification into a KS filling line. The finished unit still needs a finished COA. Customer-supplied drums follow the same qualification path.

Typical bulk talk: 25 kg HDPE drums, PE liner; smaller aluminum-foil packs for samples. Dating on the drum follows that lot’s stability file—do not copy a raw-material month count onto a gummy or tincture. CITES paperwork, when required, is a bulk-path field.

Get an OEM / private-label quote — name bulk kg vs finished units on the RFQ.

Example. The RFQ asked for 500 mg dual-marker, hard capsule. The attached sheet was R. crenulata, salidroside 3%, rosavins not listed. That drum cannot be filled as a dual-marker rosea capsule. The quotation waited until species and both analytes were rewritten.

Changing the extract supplier after approval restarts qualification: solvent profile, bulk density, particle size, and finished potency can all move.

You do not need a finished Supplement Facts panel to start. Send:

Species and plant part · extract type and grade (root powder, named-ratio, or a dual-marker pair such as 3%/1%) · marker requirements and HPLC method if markers will be printed · milligram basis (extract vs root) · dosage form and fill weight · serving count and pack · destination market · quantity · whether you need incoming-only or finished-unit assay. Two supplier COAs if you are comparing price. An NDA can be signed first.

RFQ → lock species and the dual-marker file → sample → approval → artwork (timing line and warnings) → production → batch COA → shipment.

Sample 7–15 days after specification and material confirmation. Mass production 30–45 days after formula, artwork, pack, and schedule. Gummy or tincture pilots, licensed extract names, and bulk CITES paperwork add time before those clocks. Typical first reply is one business day.

Stress / adaptogen assortment is the default shelf for a dual-marker capsule. Energy-line SKUs follow the B-complex / energy card above. Cortisol wording, if used, is destination structure/function copy—not a cortisol-lowering drug and not a third money page.

We do not develop a weight-loss rhodiola SKU. We do not print antidepressant or disease claims. Isolated salidroside as an API path is out of scope.

Same artwork worldwide? Usually no. Product name (rhodiola / golden root / 红景天), claims, warnings, Supplement Facts format, and language are destination files. UK, Australia, and Canada each need their own review; they are not country landing pages.

Export programs we already run as dietary-supplement OEM (United States, Canada, Australia, EU destinations, Middle East) still close on the destination dossier—not on a single global carton.

This section supports finished-label review. It is not medical advice.

Complaints discussed on rhodiola files include gastrointestinal discomfort, restlessness or a stimulating feel, evening use affecting sleep, and headache. Incidence varies by formula and published evidence; warning language follows the destination market.

Potential interaction-related label language should be reviewed against the destination market, formulation, and available evidence before it is finalized. Pregnancy and lactation are not default SKUs. Infant and pet products are not manufactured here. Age-related restrictions depend on the destination market and product category.

Human oral dietary supplements only.

Release has to prove species, milligram basis (root vs extract), and the dual-marker file when the panel prints it. Powder color does not close those rows. Quality control.

Third-party reports (SGS / Eurofins) when the RFQ asks. Heavy metals are controlled against the approved raw-material and finished-product specification and destination-market requirements. Customer-supplied drums follow the same qualification.

MOQ moves because the SKU moves—not because a website prints one number.

Starting conversation ranges (planning, not a quote): capsules about 3,000–5,000 units; tablets about 5,000–10,000; powder / stick often from about 10,000. Gummies and liquids after feasibility. Bulk kg is a separate line.

Default bottle pack for dry extract: HDPE, induction seal, desiccant when moisture is in the file. Blister and stick film are quoted when named. No universal “36-month finished” claim.

What is a rhodiola supplement?
On this page it is a finished oral dietary supplement made from Rhodiola rosea root and rhizome—golden root; some markets write arctic root or 红景天. Structure/function wording follows the destination file. We manufacture capsules, tablets, powders, gummies, and liquids against a named grade and a batch COA.

Can I substitute R. crenulata for R. rosea?
No. Rosea supports a rosavins conversation. Crenulata trade is usually salidroside-only. A crenulata drum quoted as dual-marker rosea is rewritten before fill.

What does 3% rosavins / 1% salidroside mean?
The usual starting dual-marker grade we quote on dry R. rosea root extract: total rosavins ≥3.0% and salidroside ≥1.0%, HPLC. It is not a universal pharmacopeial standard and not a licensed branded extract. Other pairs (3%/2%, 5%/1%, 5%/2%) and custom HPLC targets are quoted on request. Lock method and incoming vs finished-unit assay to the approved COA.

What should I include in a rhodiola RFQ?
Species, plant part, extract type and grade, marker requirements, assay method, dosage form, fill weight, serving count, packaging, destination market, and quantity. Incoming vs finished-unit assay if markers will be printed. Two COAs if you are comparing price.

Can you supply bulk Rhodiola rosea extract?
Yes as a kilogram quote for filling programs, separate from bottle MOQ. Customer-supplied drums follow the same incoming qualification; finished units still need a finished COA. CITES paperwork, when required, is a bulk-path field.

Can rhodiola be made into gummies or tinctures?
Yes after a taste-and-assay pilot. Bitterness, cook heat (gummies), and assay per piece or per mL are the project. A root-mg gummy is not a 500 mg dual-marker capsule.

What is the MOQ, and how long does production take?
MOQ depends on dosage form, packaging, flavoring, and batch requirements. Current planning ranges are shown above. First reply typically one business day. Sample 7–15 days after spec and material confirmation. Mass production 30–45 days after formula, artwork, pack, and schedule.

Can I use my own raw material?
Yes after qualification against the approved specification. Finished-unit testing still applies.

Can you produce HPMC (vegan) capsules?
Yes. Vegan capsules are HPMC hard capsules on the same root grade, not HPMC softgels.

Can you copy another brand’s Rhodiola formula?
No. We do not reverse-engineer branded retail formulas. Send a BOM and COA. We lock specification from your file.